T. Rowe Price holds 15.3% of Shattuck Labs
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 13,432,540 shares of SHATTUCK LABS INC common stock on a Schedule 13G/A (Amendment No. 2).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. reports beneficial ownership of 13,432,540 shares of SHATTUCK LABS INC common stock on a Schedule 13G/A (Amendment No. 2). This position represents 15.3% of the outstanding common stock, all with sole dispositive power and 13,391,090 shares with sole voting power.
The firm states that voting and economic benefits ultimately belong to its underlying clients, who may revoke delegated authority. The T. Rowe Price Small-Cap Value Fund is identified as holding 3,565,344 shares, or 5.6% of the class. T. Rowe Price Investment Management expressly denies beneficial ownership in its own right.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial ownership financial
sole voting power financial
sole dispositive power financial
investment adviser financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of SHATTUCK LABS INC (STTK) does T. Rowe Price Investment Management hold?
What is the stake of T. Rowe Price Small-Cap Value Fund in SHATTUCK LABS INC (STTK)?
Who ultimately receives dividends and sale proceeds from the SHATTUCK LABS INC (STTK) shares held by T. Rowe Price Investment Management?
Does T. Rowe Price Investment Management claim beneficial ownership of SHATTUCK LABS INC (STTK) shares?
AI-generated analysis. How Rhea-AI works. Not financial advice.